iSpecimen (ISPC) Expected to Announce Quarterly Earnings on Thursday

iSpecimen (NASDAQ:ISPC) is projected to post its results before the market opens on Thursday, March 12th. Analysts expect iSpecimen to post earnings of ($3.80) per share and revenue of $3.4030 million for the quarter.

iSpecimen Price Performance

Shares of ISPC stock opened at $0.26 on Thursday. The firm has a 50-day moving average of $0.32 and a 200-day moving average of $0.65. The company has a market cap of $2.49 million, a P/E ratio of -0.03 and a beta of 1.87. iSpecimen has a one year low of $0.23 and a one year high of $3.18.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of iSpecimen in a research note on Thursday, January 22nd. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has an average rating of “Sell”.

Hedge Funds Weigh In On iSpecimen

A hedge fund recently bought a new stake in iSpecimen stock. Virtu Financial LLC acquired a new stake in shares of iSpecimen Inc. (NASDAQ:ISPC) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 63,257 shares of the company’s stock, valued at approximately $82,000. Virtu Financial LLC owned 0.65% of iSpecimen at the end of the most recent quarter. 13.62% of the stock is currently owned by institutional investors and hedge funds.

iSpecimen Company Profile

iSpecimen, Inc (NASDAQ:ISPC) operates an online life sciences marketplace designed to connect researchers with human biological specimens and associated clinical data. The company’s platform streamlines the sourcing of biospecimens—such as plasma, serum, fresh and frozen tissue, saliva, urine and peripheral blood mononuclear cells (PBMCs)—by matching demand from pharmaceutical, biotechnology, diagnostic and academic organizations with supply from a wide network of clinical sites and biobanks.

Through its on-demand procurement model, iSpecimen provides customized specimen collection and fulfillment services that help accelerate research timelines and improve data quality.